Mylan, looking to capitalize on Biogen’s Tecfidera patent loss, faces fork in the road on generic launch kblankenship […]
FiercePharmaPolitics—FDA could approve ‘at least one’ COVID-19 vaccine before election: analyst esagonowsky Mon, 06/22/2020 – 09:45
Nabriva hit with another FDA setback with complete response letter for antibiotic Contepo kblankenship Mon, 06/22/2020 – 08:13
A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically […]
Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. […]
Chronic traumatic encephalopathy (CTE), a neurodegenerative disease caused by repeated head injuries often affecting athletes, can only be […]
Local health protection teams have traced nearly eight times more contacts (77 642) than the national call centres […]
Where did the UK’s covid-19 plan go wrong?1 Politics. Despite repeated assurances that it was “following the science,” […]
What you need to knowAlways consider reasons for decompensation in heart failure, as they may require specific treatmentAfter […]
